Suppr超能文献

雷诺嗪在慢性稳定性心绞痛患者中的应用

Utility of ranolazine in chronic stable angina patients.

作者信息

Patel Pawan D, Arora Rohit R

机构信息

Department of Cardiology, Chicago Medical School, North Chicago, IL 60064, USA.

出版信息

Vasc Health Risk Manag. 2008;4(4):819-24. doi: 10.2147/vhrm.s2841.

Abstract

Chronic stable angina is a debilitating illness affecting at least 6.6 million US residents. Despite being optimally treated by pharmacotherapy and revascularization up to 26% of patients still experience angina. Diabetes mellitus is a common co-morbid condition in angina patients. Several new investigational medications are being tested for chronic angina. Advances in understanding of myocardial ischemia have prompted evaluation of a number of new antianginal strategies. In this review we discuss the utility of ranolazine, a recently approved novel antianginal agent and its efficacy in the diabetic patient population. In addition to its antianginal action in diabetic patients with chronic angina, ranolazine may have favorable effects on glycated hemoglobin levels.

摘要

慢性稳定性心绞痛是一种使人虚弱的疾病,影响着至少660万美国居民。尽管通过药物治疗和血运重建进行了最佳治疗,但仍有高达26%的患者会出现心绞痛。糖尿病是心绞痛患者常见的合并症。几种新的研究性药物正在针对慢性心绞痛进行测试。对心肌缺血认识的进展促使人们评估了许多新的抗心绞痛策略。在本综述中,我们讨论了雷诺嗪(一种最近获批的新型抗心绞痛药物)的效用及其在糖尿病患者群体中的疗效。除了对患有慢性心绞痛的糖尿病患者具有抗心绞痛作用外,雷诺嗪可能对糖化血红蛋白水平有有利影响。

相似文献

1
Utility of ranolazine in chronic stable angina patients.
Vasc Health Risk Manag. 2008;4(4):819-24. doi: 10.2147/vhrm.s2841.
2
Ranolazine: a review of its use in chronic stable angina pectoris.
Drugs. 2006;66(5):693-710. doi: 10.2165/00003495-200666050-00010.
5
Ranolazine: a review of its use in chronic stable angina pectoris.
Drugs. 2008;68(17):2483-503. doi: 10.2165/0003495-200868170-00006.
6
Ranolazine for the management of coronary artery disease.
Clin Ther. 2006 Dec;28(12):1996-2007. doi: 10.1016/j.clinthera.2006.12.009.
8
Spotlight on ranolazine in chronic stable angina pectoris.
Am J Cardiovasc Drugs. 2006;6(5):357-9. doi: 10.2165/00129784-200606050-00009.
9
Extended-release ranolazine: critical evaluation of its use in stable angina.
Vasc Health Risk Manag. 2011;7:535-9. doi: 10.2147/VHRM.S15560. Epub 2011 Aug 25.

引用本文的文献

1
Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm.
Clin Case Rep. 2017 Jun 2;5(7):1170-1175. doi: 10.1002/ccr3.1019. eCollection 2017 Jul.
2
Ranolazine for stable angina pectoris.
Cochrane Database Syst Rev. 2017 Feb 8;2(2):CD011747. doi: 10.1002/14651858.CD011747.pub2.
4
Transmyocardial revascularization devices: technology update.
Med Devices (Auckl). 2014 Dec 18;8:11-9. doi: 10.2147/MDER.S51591. eCollection 2015.

本文引用的文献

4
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
5
Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
J Am Coll Cardiol. 2007 Mar 13;49(10):1027-34. doi: 10.1016/j.jacc.2006.10.067. Epub 2007 Feb 26.
6
Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
Am J Cardiol. 2007 Jan 1;99(1):11-8. doi: 10.1016/j.amjcard.2006.07.052. Epub 2006 Nov 2.
7
Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.
J Mol Cell Cardiol. 2006 Dec;41(6):1031-8. doi: 10.1016/j.yjmcc.2006.08.012. Epub 2006 Oct 5.
8
Current strategies for the prevention of angina in patients with stable coronary artery disease.
Curr Opin Cardiol. 2006 Sep;21(5):492-502. doi: 10.1097/01.hco.0000240588.22086.43.
9
Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
J Am Coll Cardiol. 2006 Aug 1;48(3):566-75. doi: 10.1016/j.jacc.2006.05.044. Epub 2006 Jun 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验